Abstract:Objective To investigate our experience in the diagnosis and treatment of acute graft-versus-host disease（a GVHD） after liver transplantation in surgical ICU. Methods We retrospectively analyzed the general data,clinical manifestation,diagnosis,and treatment strategies of five patients with a GVHD after liver transplantation in The First Affiliated Hospital of Xi’an Jiaotong University from January 2000 to December 2019. Results The incidence rate of a GVHD was 5/850（5.88 ‰）, and all the five patients were male and aged 40-64 years（mean age56 years）. Diabetes, hepatocellular carcinoma, liver transplantation, transcatheter arterial chemoembolization（TACE）, and high concentration of immune agents were the main risk factors associated with the development of aG VHD. The average time from surgery until clinical symptom of aG VHD was 15 to 32 days. In our patients with aG VHD, the most common symptom was fever（5/5）, followed by skin rash（5/5）, pancytopenia（5/5）, diarrhea（3/5）, and secondary pulmonary infection（3/5）. However, liver functions were not remarkable affected. Diagnostic criteria for aG VHD in our center include acute onset, risk factors, typical clinical manifestation, and histopathology after exclusion of differential diseases. Our treatment strategies include high-dose methylprednisolone, stopping/reducing current immunosuppressive protocol, and antilymphocytic agents as secondline treatment. Empirical antibiotics and antifungal agents play a vital part in infections after transplantation. Hematopoietic cytokine was administered to treat pancytopenia. Patients also received supportive therapy, such as isolation and nutritional support, with the goal of benefiting the entire condition. Despite intensive treatment, two of five patients（40%） with aG VHD died due to sepsis and multiorgan failure. One case（20%） died of intracranial hemorrhage and one case（20%） died of tuberculosis. Only one case（20%） stayed alive after 1-year follow-up without complications. Conclusion The diagnosis of aG VHD relies on clinical suspicion and is confirmed by skin pathology. The patients with aG VHD had early onset（＜30 day）, high peak temperature（＞38.5 ℃）, large rash range（＞50%）, complication of sepsis,and poor response to hematopoietic cytokine therapy indicate poor prognosis. Intensive treatment should be started immediately after aG VHD diagnosis. In conclusion, we strongly suggest an early identification, diagnosis, and vigorous treatment strategy, which is the key to improving the prognosis of aG VHD.

[Graft Versus Host Disease after Liver Transplantation: a Report of 3 Cases].

Graft versus host disease following liver transplantation: A case report.

Diagnosis and Treatment of Graft Versus Host Disease after Liver Transplantation

PRELIMINARY CHINICAL EXPERIENCE OF LIVER TRANSPLANT-ASSOCIATED GRAFT-VERSUS-HOST DISEASE.

Diagnosis and treatment of acute graft-versus-host disease after liver transplantation: Report of six cases

Clinical analysis of 6 cases of graft-versus-host disease after liver transplantation

Experience in Diagnosis and Treatment of Acute Graft-Versus-host Disease after Liver Transplantation of Five Cases

Acute Graft-vs-Host Disease After Liver Transplantation in a Patient Presenting With Neurogenic Symptoms as the Single Primary Manifestation: A Case Report.

Clinical Immune Tolerance after Healing of Acute Graft-Versus-host Disease Following Liver Transplantation:One Case Report

Unsuccessful Treatment of Four Patients with Acute Graft-Vs-host Disease after Liver Transplantation

Late Onset of Severe Graft‐versus‐host Disease Following Liver Transplantation

Progress of the Giagnosis and Treatment of Postoperative Liver Transplant-Associated Graft Versus Host Disease

Successful Salvage Treatment of Acute Graft-Versus-host Disease after Liver Transplantation by Withdrawal of Immunosuppression: a Case Report.

Expansion kinetics of graft‐versus‐host T cell clones in patients with post‐liver transplant graft‐versus‐host disease

Transplant Associated Graft versus Host Disease

Diagnosis And Differential Diagnosis Of Hepatic Graft Versus Host Disease (Gvhd)

Etiological diagnosis and management of chronic graft dysfunction after liver transptantation: an analysis of 18 cases

Clinical Analysis and Proteomic Screening Biomarkers for Graft-Versus-Host Disease After Liver Transplant

Intestinal graft-versus-host disease after allogeneic hemapoietic stem cell transplantation

GRAFT-VERSUS-HOST DISEASE AND XENOTRANSPLANTATION

Characteristics and Risk of Chronic Graft-Versus-host Disease of Liver in Allogeneic Hematopoietic Stem Cell Transplant Recipients